# A Study in Adult and Pediatric Patients With Cystic Fibrosis

> **NCT00034515** · PHASE1,PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 63 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** denufosol tetrasodium (INS37217) Inhalation Solution

## Key facts

- **NCT ID:** NCT00034515
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034515, "A Study in Adult and Pediatric Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00034515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*